Catalyst
Slingshot members are tracking this event:
Agios (AGIO) to Present Data on Expansion Phase 1 Study of AG-120 in Advanced 1DH1 Mutant Positive Low-Grade Glioma in the Second Half of 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AGIO |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 18, 2016
Occurred Source:
http://investor.agios.com/phoenix.zhtml?c=251862&p=irol-newsArticle&ID=2223601
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Expansion Phase, Phase 1, Ag-120, Advanced Idh1 Mutant Positive Low-grade, Glioma, Data Release
